drugset

drugset / Trial / NCT06661811

A Study of CAR-T Cells Targeting Autoimmune Diseases

NCT06661811 ↗

Not yet recruiting 12 enrolled Beijing Boren Hospital

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in patients with autoimmune disease.

Timeline

Start: 2024-11-15
Primary completion: 2028-04-20
Completion: 2028-06-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CAR-T	Cell therapy	—	—

Indications